SCHEMBL18364658

SCHEMBL18364658

Oc1cccc2cc(C(O)c3c[nH]c4ccccc34)ccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
GPR84 Q9NQS5 3/20 0.43
FFAR1 O14842 2/20 0.43
AHR P35869 1/20 0.43
CYP1A2 P05177 2/20 0.41
MGAM O43451 6/20 0.40
GAA P10253 6/20 0.40
SI P14410 6/20 0.40
MGAM2 Q2M2H8 6/20 0.40
GUSB P08236 1/20 0.39
PLAU P00749 1/20 0.39
ALDH1A1 P00352 1/20 0.39
TP53 P04637 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18364649 0.86 MEN1 (0.48) MAPTMEN1KMT2ANPSR1TDP1
SCHEMBL6379817 0.81 MAPT (0.56) MAPTMEN1KMT2ANPSR1TDP1
SCHEMBL18364646 0.81 MAPT (0.48) MAPTMEN1KMT2ANPSR1TDP1
SCHEMBL13763231 0.75 MAPT (0.59) MAPTMEN1KMT2ANPSR1GPR84
SCHEMBL18364647 0.75 MAPT (0.52) MAPTMEN1KMT2ANPSR1TDP1
SCHEMBL8213938 0.74 MAPT (0.67) MAPTMEN1KMT2ATDP1GPR84
SCHEMBL21202534 0.73 HSD17B1 (0.36) MEN1KMT2APLAUHSD17B1HSD17B2
SCHEMBL13763230 0.73 MGAM (0.58) MAPTMEN1KMT2ANPSR1TDP1
SCHEMBL28767073 0.73 MAPT (0.54) MAPTMEN1KMT2ANPSR1TDP1
SCHEMBL18364667 0.73 MAPT (0.54) MAPTMEN1KMT2ANPSR1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170008843-A1 MONOMER, ORGANIC LAYER COMPOSITION, ORGANIC LAYER, AND METHOD OF FORMING PATTERNS SAMSUNG SDI CO., LTD. (KR) 2017-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170008843-A1 MONOMER, ORGANIC LAYER COMPOSITION, ORGANIC LAYER, AND METHOD OF FORMING PATTERNS MSMO1, NOM1, CD68 MAPT 293/4885MEN1 407/4885KMT2A 3422/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.